Therefore, our findings of differential expression of DNMT1, DNMT3, DNMT3B and UHRF1 in AD and ZBTB4 and MeCP2 in TBI could lead to alterations in complex binding which is consistent with causing changes to DNA methylation sites. Here, MECP2 is linked to Alzheimer disease.